timoprazole has been researched along with Gastric Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (50.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Davis, JP; Lancaster, C; Nezamis, JE; Nichols, NM; Ochoa, R; Rush, BD; Ruwart, MJ | 1 |
| Babul'ová, A; Bauer, V; Nosál'ová, V | 1 |
2 other study(ies) available for timoprazole and Gastric Diseases
| Article | Year |
|---|---|
Timoprazole is a unique cytoprotective agent in the rat.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Adenosine Triphosphatases; Animals; Benzimidazoles; Ethanol; Female; Gastric Acid; Gastrointestinal Hemorrhage; H(+)-K(+)-Exchanging ATPase; Hot Temperature; Hydrochloric Acid; Necrosis; Omeprazole; Parietal Cells, Gastric; Prostaglandins; Rats; Stomach Diseases | 1984 |
Gastric transmucosal potential difference: effect of antisecretory and gastroprotective drugs.
Topics: 2-Pyridinylmethylsulfinylbenzimidazoles; Animals; Anti-Ulcer Agents; Benzimidazoles; Carbamates; Dinoprostone; Electrophysiology; Ethanol; Female; Gastric Mucosa; Omeprazole; Ranitidine; Rats; Rats, Wistar; Stomach Diseases | 1998 |